Hemodynamic changes and prognosis in patients with hypertrophic cardiomyopathy and abnormal blood pressure responses

Mitsuru Nagata1, Masami Shimizu, Hidekazu Ino

  • 1Molecular Genetics of Cardiovascular Disorders, Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Clinical Cardiology
|March 11, 2003
PubMed

Insights

Abnormal blood pressure response (BPR) during exercise in hypertrophic cardiomyopathy (HCM) patients is linked to a higher risk of cardiac events. This may be due to a lack of stroke volume increase, not heart rate or vascular resistance changes.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Clinical Medicine

Background:

  • Abnormal blood pressure response (BPR) during exercise is a potential risk factor for sudden cardiac death in hypertrophic cardiomyopathy (HCM) patients.
  • Some HCM patients exhibit systolic dysfunction during exercise, highlighting the need for further investigation into exercise hemodynamics.

Purpose of the Study:

  • To investigate the hemodynamic response during exercise in patients with HCM and abnormal BPR.
  • To clarify the long-term prognosis for HCM patients experiencing abnormal BPR during exercise.

Main Methods:

  • Sixty-five HCM patients underwent radionuclide monitoring of left ventricular function and blood pressure measurements during supine ergometer exercise.
  • Cardiac events were prospectively recorded for an average follow-up period of 76 months.

Main Results:

  • Seven out of 65 patients (11%) exhibited abnormal BPR; the remaining had normal BPR.
  • Stroke volume failed to increase in the abnormal BPR group, unlike the normal BPR group.
  • Patients with abnormal BPR had a significantly higher incidence of malignant arrhythmias (43%) compared to those with normal BPR (2%) during follow-up.

Conclusions:

  • Abnormal BPR in nonobstructive HCM is associated with a high prevalence of cardiac events.
  • The primary predictor of abnormal BPR during exercise appears to be an inadequate increase in stroke volume, rather than alterations in systemic vascular resistance or heart rate.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...